Table 5.

Quality-of-life changes during therapy

	Initial	Week 7	Week 24
Kings sarcoidosis questionnaire
GHS	49.8 (15.9–70.9)a	54.3 (31.7–100)b	58.1 (23.8–100)c
GHS Lung	51.5 (41.0–68.0)	57.8 (47.7–100)d	56.9 (44.3–100)f
Lung	42.8 (22.3–61.0)	54.4 (33.6–100)e	49.6 (37.2–100)
Saint George respiratory questionnaire
SGRQ activity	74.44 (35.24–92.51)	72.82 (41.63–92.51)	72.82 (47.69–92.51)
SGRQ impacts	36.68 (13.75–70.34)	40.92 (19.34–66.55)	42.52 (17.19–66.7)
SGRQ symptoms	53.465 (17.24–92.65)	57.98 (32.51–90.26)	46.28 (7.63–85.84)
SGRQ total	51.49 (21.89–77.21)	54.88 (34.1–70.31)	54.13 (25.4–71.1)
Fatigue assessment scale
FAS	28 (15–46)	26 (10–37)	22 (11–42)g

^aMedian (range). GHS general health status

^bCompared to week 0, p = 0.0043

^cCompared to week 0, p = 0.0084

^dCompared to week 0, p = 0.0034

^eCompared to week 0, p = 0.0067

^fCompared to week 0, p = 0.0107

^gCompared to week 0, p = 0.0067